Experienced in Multiple Myeloma

Philipp Beckhove

Franz Josef Strauss Allee 11, 
Regensburg, BY, DE 
Experienced in Multiple Myeloma
Franz Josef Strauss Allee 11, 
Regensburg, BY, DE 
OverviewLocationsClinical Research

Overview

Philipp Beckhove practices in Regensburg, Germany. Mr. Beckhove is rated as an Experienced expert by MediFind in the treatment of Multiple Myeloma. His top areas of expertise are Glioblastoma, Astrocytoma, Glioma, Gliomatosis Cerebri, and Bone Marrow Transplant.

His clinical research consists of co-authoring 99 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 4 articles in the study of Multiple Myeloma.

Gender
Male

Locations

Franz Josef Strauss Allee 11, Regensburg, BY 93053, Germany

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

A Randomized Phase II Study of Radiation Induced Immune Boost in Operable Non-small Cell Lung Cancer
A Randomized Phase II Study of Radiation Induced Immune Boost in Operable Non-small Cell Lung Cancer
Enrollment Status: Completed
Publish Date: May 23, 2022
Intervention Type: Radiation
Study Phase: Not Applicable
Randomised Phase I/II Trial in Order to Evaluate the Effect of Neoadjuvant Radiation on Tumor Infiltrating T-cells by Neoadjuvant Low-Dose-Radiation Therapy in Primarily Resectable Pancreatic Cancer
Randomised Phase I/II Trial in Order to Evaluate the Effect of Neoadjuvant Radiation on Tumor Infiltrating T-cells by Neoadjuvant Low-Dose-Radiation Therapy in Primarily Resectable Pancreatic Cancer
Enrollment Status: Completed
Publish Date: June 10, 2021
Intervention Type: Radiation
Study Phase: Not Applicable
View 1 Less Clinical Trial

99 Total Publications

Mucosal calprotectin is associated with severity of aGI-GVHD and poor outcomes after allogeneic stem cell transplantation.
Mucosal calprotectin is associated with severity of aGI-GVHD and poor outcomes after allogeneic stem cell transplantation.
Journal: Blood
Published: March 28, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Beckhove's expertise for a condition
ConditionClose
      View All 17 Experienced Conditions
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile